Having counseled thousands of patients through their breast cancer diagnosis, I was fully aware of how nondiscriminatory this ...
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
The FDA has approved AstraZeneca and Daiichi Sankyo’s Datroway (datopotamab deruxtecan-dlnk) to treat unresectable or ...
Heart disease increases the likelihood of advanced breast cancer. Hormone receptor-positive tumors are linked to ...
Low-dose oral minoxidil, the hair growth drug which is the active ingredient in Rogaine, may be safe and effective for ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Even if a patient is unable to beat the disease, early-stage detection of cancer can play a crucial role in increasing their ...
At Allegheny General Hospital, a new pilot program is focusing on patients diagnosed with metastatic breast cancer. It's a ...
It’s been months in the making, but now the new resource is available for those battling the treatable, but incurable form of ...
A new analysis of the Breast Cancer Index (BCI) may help identify women with HR-positive breast cancer who could potentially ...
The American Cancer Society is asking North Dakota State lawmakers to pass legislation that would require insurance companies to cover diagnostic testing for people who need it when doctors find ...